An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial

Abstract

Background Pre-exposure prophylaxis (PrEP) is highly efficacious for preventing HIV but has not yet been brought to scale among at-risk persons. In several clinical trials in urban areas, technology-based interventions have shown a positive impact on PrEP adherence. In rural and small-town areas in the United States, which often do not have geographically proximal access to PrEP providers, additional support may be needed. This may be particularly true for younger persons who are more likely to face multiple barriers to accessing PrEP services. Home-based care, accomplished through a tailored mobile phone app, specimen self-collection (SSC), and interactive video consultations, could increase both PrEP initiation and persistence in care. Objective The goal of this study is to assess the initiation and persistence in PrEP care for those randomized to a home-care intervention (electronic PrEP, ePrEP) relative to those assigned to the standard of care (control) condition. We will conduct additional assessments, including quantitative and qualitative analyses, to contextualize trial results and facilitate scale-up. Methods This 2-arm, randomized controlled trial will enroll young men who have sex with men (YMSM) aged between 18 and 24 years from rural areas of Georgia, Mississippi, and North Carolina. The trial will seek to recruit a diverse sample, targeting 50% participation among highly impacted groups of black or Latino men who have sex with men. Intervention participants will receive a study app that incorporates a messaging platform, a scheduling and milestone-based tracking system for PrEP care progress, electronic behavioral surveys, and interactive video consultations with a clinician. Complemented by SSC kits mailed to laboratories for standard PrEP-related monitoring, the ePrEP system will allow participants to access PrEP care without leaving their homes. YMSM randomized to the control condition will receive a listing of nearest local PrEP providers to receive standard PrEP care. Both groups will complete quarterly electronic surveys. The primary outcome, assessed at 6 and 12 months after randomization, will be the difference in the proportion of intervention versus control participants that achieve protective levels of the active metabolite of oral PrEP (tenofovir diphosphate in dried blood spots). Results Enrollment will begin in May 2019, with study completion in 2022. Conclusions This trial will determine whether home PrEP care provided through an app-based platform is an efficacious means of expanding access to PrEP care for a diverse group of YMSM in rural and small-town areas of the United States. Trial Registration ClinicalTrials.gov NCT03729570; https://clinicaltrials.gov/ct2/show/NCT03729570 (Archived by WebCite at http://www.webcitation.org/78RE2Qizf) International Registered Report Identifier (IRRID) PRR1-10...

Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions

“…We anticipate that the scale will likely perform well across diverse settings, however, future research is needed to provide additional validation across other groups and settings. We are currently investigating how the scale will perform in a study that targets recruitment of over 190 Black MSM in urban areas, [53] and also in a study that targets recruitment of over 120 Latino MSM or Black MSM in rural areas [54]. It is important to note that for the present study, although we did not observe significant differences in mean scale scores by race/ethnicity, we did not have sufficient sample size to adequately assess potential areas of difference.…”

Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions

“…Table 1 provides information about current iTech studies, including current enrollment status. All studies have been described previously [8][9][10][11][12][13][14]; additional information about iTech can be found at itechnetwork.org.…”

Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response

“…We have estimated that we will have 22% response, a level lower than reported willingness to participate in home testing studies for COVID-19 research [ 24 ], to account for the possibility that the willingness contingency valuation overestimated willingness. We will seek to enhance retention abilities by collecting a full set of detailed contact information at the baseline, and by using multiple modes of contact strategies at follow-up, strategies we have successfully used in other remote home testing studies [ 32 , 62 , 63 ]. We will perform analyses at the follow-up period to assess ways in which differential retention across subgroups might impact study findings.…”